Transdermal Scopolamine and Toxic Psychosis
Authors: KIRK J. RODYSILL
Journal: Annals of Internal Medicine (1983)

Letters and Corrections1 April 1983Transdermal Scopolamine and Toxic PsychosisKIRK J. RODYSILL, M.D., J. BRYAN WARREN, M.D.KIRK J. RODYSILL, M.D.Search for more papers by this author, J. BRYAN WARREN, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-98-4-561_2 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: Toxic psychosis associated with the use of belladonna alkaloids is well documented (1). Transdermal scopolamine (Transderm-V; Ciba-Geigy Corp., Summit, New Jersey) is now available for treatment of motion sickness. Transdermal administration has been reported to prevent many of the adverse effects associated with oral scopolamine (2). We report a case of a patient with toxic delerium associated with transdermal scopolamine.Transdermal scopolamine, 0.5 mg, was prescribed for a 76-year-old woman with persistent vertigo and nausea after she had herpes zoster oticus. Approximately 8 hours after applying a patch without removing one already in place, the patient developed...References1. GOODMANGILLMAN LA. The Pharmacological Basis of Therapeutics: A Textbook of Pharmacology, Toxicology and Therapeutics for Physicians and Medical Students. 4th ed. New York: MacMillan Publishing Company; 1970:534. Google Scholar2. Transdermal scopolamine for motion sickness. Med Lett. 1981;23:89-90. Google Scholar3. OSTERHOLMCAMORIANO RJ. Transdermal scopolamine psychosis [Letter]. JAMA. 1982;247:3081. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: St. Paul-Ramsey Medical Center St. Paul, MN 55101 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByThe efficacy of scopolamine for patients with Parkinson's disease and depression: Two case reportsAnesthesia for LiposuctionAnesthesia for Aesthetic SurgeryAnesthesia for Minimally Invasive Cosmetic Surgery of the Head and NeckPsychosis From Anticholinergic Medications Administered at a Smoking Cessation ClinicMental confusion associated with scopolamine patch in elderly with mild cognitive impairment (MCI)Transdermal Scopolamine for Prevention of Motion SicknessThree Cases of Substitution Errors Leading to Hyoscine Hydrobromide OverdoseGlycopyrrolate Treatment Of Drooling In An Adult Male Patient With Cerebral PalsyEpidural scopolamine administration in preventing nausea after epidural morphineThe Relationship between Comprehensive Functional Assessment and Optimal Pharmacotherapy in the Older PatientTransdermal scopolamine—induced psychosisSide effects of transdermal scopolamineDermatological drugs and cosmeticsTOXIC PSYCHOSIS FROM TRANSDERMAL SCOPOLAMINE IN A CHILDAnesthesia for Liposuction and AbdominoplastyAnesthesia for Minimally Invasive Cosmetic Surgery of the Head and Neck 1 April 1983Volume 98, Issue 4Page: 561-561KeywordsAlkaloidsNauseaVertigo Issue Published: 1 April 1983 PDF DownloadLoading ...